Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03497767
Title A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases (OUTRUN)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Trans Tasman Radiation Oncology Group
Indications

lung non-small cell carcinoma

Therapies

Osimertinib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.